The COX-2-PGE2 signaling pathway may assist tumors in evading immune systems by inducing tumor-associated immune cells aggregation, impaired APC activity, a switch from Th1 to Th2 and Th17 immune responses or by suppressing CD8+ cytotoxic T cell and NK cell functions to promote tumor immune escape. The gene discussed is PTGS2; the disease is neoplasm.